Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 10, 2011

View Archived Issues

Aspirin lowers risk of colorectal cancer in Lynch syndrome

Recommended phase II dose of serdemetan determined in patients with advanced solid tumors

Fostamatinib shows long-term safety in rheumatoid arthritis

Merck & Co. reports progress of third quarter 2011

Amgen announces highlights of third quarter 2011

Eisai starts phase I trial of candidate insomnia therapy

Enrollment begins in Genetech's phase II GDC-0980 trial in endometrial cancer

Celldex Therapeutics begins phase I trial of CDX-1127

Avir Green Hills Biotechnology reports on flu vaccine

Calcium-activated K(Ca)1.1 potassium channel activator shows promise in model of bladder dysfunction

PROVIDE trial examines boceprevir in patients with refractory hepatitis C

Study assesses dose-response relationship of arthritis therapy

Novel antitumor compound prepared at Chinese university

Access Pharmaceuticals signs agreement for RNAi delivery technology

FDA accepts MoxDuo IR NDA for review

New tranylcypromine derivatives designed in Italy

Children's Hospital Boston and Pfizer to research muscular dystrophy therapeutics

Merck & Co. launches Nexplanon in U.S.

Peking University synthesizes novel agents to treat cancer

Sinovac reports preliminary phase II data on vaccine for hand, foot and mouth disease

Unigene discloses topline phase II data on oral parathyroid hormone analogue

Merck & Co. claims new products for anemia

Dako and BMS build on pharmacodiagnostics collaboration

MIT discloses novel targeted siRNA nanocomplexes for ovarian cancer

Sanofi and Regeneron report on phase II hypercholesterolemia program

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...